SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-140888
Filing Date
2015-04-22
Accepted
2015-04-22 06:07:38
Documents
3
Period of Report
2015-06-09
Effectiveness Date
2015-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d871104ddef14a.htm DEF 14A 592166
2 GRAPHIC g871104g07o65.jpg GRAPHIC 12466
3 GRAPHIC g871104g80i40.jpg GRAPHIC 6878
  Complete submission text file 0001193125-15-140888.txt   620188
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33415 | Film No.: 15784402
SIC: 2834 Pharmaceutical Preparations